A human study to evaluate the bioavailability, anti-inflammation, and safety of Agastache rugosa extracts in healthy women

Ewha Womens University0 个研究点目标入组 10 人开始时间: 待定最近更新: 2021年11月2日

试验速览

暂无简介。

•1) Subject who voluntarily agree to participate and signs informed consent form
•2) Subject who can participate in all visits (total of twice) after random assignment.
•2) healthy women aged over 20 years old and under 40 years old

•1) presence of disease :
•chronic inflammatory disease, diabetes, liver or kidney disease, cardiovascular disease, uncontrolled hypertension (systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg), or thyroid disease, etc.
•2) taking medication and oriental medicine that may affect antioxidant/anti-inflammatory properties, blood glucose and blood lipids within the preceding 4 weeks
•3) continuous consumption of dietary supplements within the preceding 4 week
•4) body mass index (BMI) of less than 18.5 kg/m2 or greater than 30 kg/m2
•5) a history of body weight change = 4 kg within the preceding 4 weeks
•6) alcoholism
•7) smokers
•8) subjects were unable to maintain their current lifestyle (exercise, diet, etc.) during the exam period
•9) participation in another clinical trial within the preceding 4 weeks
•10) pregnancy or lactation
•11) hypersensitivity to Agastache rugosa or any ingredients in the study product
•12) investigator’s determination of unsuitability for the trial

发起方

Ewha Womens University